The global lipid market size is expected to reach USD 23.31 billion by 2030, registering a CAGR of 6.9% over the forecast period, as per the new report by Grand View Research, Inc. The growth is majorly driven by the rising utilization of products including dietary supplements, functional foods, functional beverages, pharmaceuticals, and more. In addition, increasing demand for lipids in the formulation of vaccines for COVID-19 has further escalated the industry growth. Lipid nanoparticles have high demand due to their wide usage in the pharmaceutical industry as a result of their high efficiency in delivering therapeutics. During COVID-19, it was widely used for transferring mRNA to cells.
Population growth in Asia Pacific has been a key factor for the steady growth of various application industries in the region. Rising consumption of consumer products, healthcare products, foods & beverages, etc. has augmented the demand for chemical ingredients in the region. In addition, the region has the presence of major market players, such as Cargill Inc., BASF SE, and Kerry Group plc, which have been producing lipids in large volumes to fulfill the requirements in the region. The increasing consumption of beverages in China also supports regional growth. Chinese consumers are more inclined toward functional beverages that contain ingredients beneficial to health.
The easy availability of sources, such as plants and animals, has resulted in an increased number of suppliers of raw materials, thereby boosting the region’s growth. However, this results in intense competition in the market, which leads to an inconsistency in prices as well as the availability of raw materials. The pandemic has had a positive impact on market growth. It has also augmented the demand for dietary supplements and medicines. Furthermore, product consumption in the pharmaceuticals industry, particularly for the formulation of COVID-19 vaccines, enhanced its demand during the pandemic.
Request a free sample copy or view the report summary: Lipid Market Report
Triglycerides will be the fastest-growing product segment from 2023 to 2030 on account of the growing product consumption in the production of nutritional foods, dietary supplements, pharmaceuticals, and more
The food & beverages application segment will register the fastest CAGR from 2023 to 2030 owing to the increasing consumption of food on the account of the rising population
Asia Pacific will the fastest-growing region from 2023 to 2030due to the increasing consumption of functional foods, dietary supplements, and medicines in countries like China and India
The presence of government regulations related to the production and consumption of lipids in different countries, owing to the usage of plants & animals for their production, may hinder the industry growth to some extent
The ongoing European geopolitical conflict between Russia and Ukraine has led to a rise in the prices of oil, energy, natural gas, etc. This situation has resulted in the price hike of raw materials for lipid production
Grand View Research has segmented the global lipid market on the basis of product, phase, application, and region:
Lipid Product Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)
Ionizable Lipids
Triglycerides
Sphingolipids
Phospholipids
Others
Lipid Phase Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)
Clinical
Pre-clinical
Others
Lipid Application Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)
Pharmaceuticals
Vaccines & Drugs
Scientific Research
Nutrition & Supplements
Food & Beverages
Others
Lipid Regional Outlook (Volume, Kilotons; Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Spain
Italy
Belgium
Russia
Turkey
Asia Pacific
China
India
Japan
Australia
Indonesia
Thailand
Philippines
Malaysia
Vietnam
South Korea
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Saudi Arabia
South Africa
UAE
Egypt
Nigeria
List of Key Players in the Lipid Market
Precision NanoSystems
Evonik Industries AG
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemicals Co. Ltd.
Lipoid GmbH
Cargill, Inc.
BASF SE
Archer Daniels Midland Company
Koninklijke DSM N.V.
Kerry Group plc
Nordic Naturals, Inc.
Clover Corp.
Croda International plc
Lipoid Kosmetik AG
Omega Protein Corp.
"The quality of research they have done for us has been excellent..."